Trial Profile
Effect of irbesartan,angiotensin 2 receptor antagonist(ARB)for urinary marker of the hypertensive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 15 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan
- 17 Sep 2013 New trial record